Rat intermedin1-47 does not improve functional recovery in postischemic hearts

Area of Science:

• Cardiovascular Physiology
• Molecular Cardiology
• Pharmacology

Background:

• Intermedin, a novel calcitonin/calcitonin gene-related peptide family member, has unclear direct effects on cardiac function.
• Understanding intermedin's impact on cardiomyocytes versus the whole heart is crucial.
• Investigating intermedin's role in post-ischemic cardiac recovery is needed.

Purpose of the Study:

• To compare intermedin's direct contractile effects on isolated cardiomyocytes and whole rat hearts.
• To determine if intermedin improves post-ischemic cardiac recovery independently of acute reperfusion injury.

Main Methods:

• Isolated adult rat ventricular cardiomyocytes were electrically paced to measure cell shortening and calcium transients.
• Isolated rat hearts underwent Langendorff perfusion, subjected to ischemia-reperfusion, and treated with intermedin.
• Nitric oxide synthesis inhibition was used to assess its role in intermedin's effects.

Main Results:

• Intermedin enhanced cardiomyocyte contractility and improved calcium transients via protein kinase A activation.
• In isolated hearts, intermedin reduced left ventricular developed pressure, an effect attenuated by nitric oxide synthesis inhibition.
• Intermedin induced significant vasodilation in both nonischemic and post-ischemic hearts.
• In post-ischemic hearts, the negative inotropic effect was reduced, but no positive effect on cardiac performance was observed.

Conclusions:

• Intermedin exhibits differential effects on cardiomyocytes and the whole heart, likely due to preferential binding to vascular cells.
• Nitric oxide pathways modulate intermedin's negative inotropic effect in the whole organ.
• Intermedin does not improve cardiac performance post-ischemia independent of acute reperfusion injury, despite its vasodilatory actions.